Hoth Therapeutics Shares Are Trading Higher After the Company Was Awarded a US Patent for Its HT-ALZ Alzheimer's Treatment and Announced Plans to Prepare for Clinical Trials to Further Validate Its Efficacy in Humans.
Hoth Therapeutics Shares Are Trading Higher After the Company Was Awarded a US Patent for Its HT-ALZ Alzheimer's Treatment and Announced Plans to Prepare for Clinical Trials to Further Validate Its Efficacy in Humans.
hoth therapeutics股价上涨，因公司被授予ht-ALZ阿尔茨海默症治疗的美国专利，并宣布计划为进一步验证其在人类中的有效性而准备临床试验。
Hoth Therapeutics Shares Are Trading Higher After the Company Was Awarded a US Patent for Its HT-ALZ Alzheimer's Treatment and Announced Plans to Prepare for Clinical Trials to Further Validate Its Efficacy in Humans.
hoth therapeutics股价上涨，因为该公司获得了其Ht-ALZ阿尔茨海默病治疗药物的美国专利，并宣布计划准备进行临床试验以进一步验证其在人类中的有效性。
资讯热榜
更新时间